Capital International Inc’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-18,566	Closed	-$1.58M	–	306
2021 Q4	$1.58M	Sell	18,566 -272,138	-94%	-$25M	0.01%	264
2021 Q3	$27.9M	Sell	290,704 -46,763	-14%	-$4.42M	0.27%	109
2021 Q2	$32.8M	Sell	337,467 -19,907	-6%	-$1.91M	0.29%	113
2021 Q1	$34.8M	Sell	357,374 -40,605	-10%	-$4.26M	0.32%	111
2020 Q4	$38.1M	Sell	397,979 -7,975	-2%	-$770K	0.35%	103
2020 Q3	$39M	Sell	405,954 -83,510	-17%	-$9.66M	0.43%	84
2020 Q2	$59.7M	Buy	489,464 +7,068	+1%	+$781K	0.73%	43
2020 Q1	$41.8M	Sell	482,396 -40,419	-8%	-$3.96M	0.7%	59
2019 Q4	$56.2M	Sell	522,815 -7,969	-2%	-$834K	0.78%	49
2019 Q3	$47.8M	Buy	530,784 +510,286	+2,489%	+$47.7M	0.72%	56
2019 Q2	$1.73M	Buy	20,498 +1,348	+7%	+$111K	0.12%	133
2019 Q1	$1.69M	Buy	19,150 +3,500	+22%	+$293K	0.2%	96
2018 Q4	$1.12M	Buy	+15,650	New	+$1.5M	0.15%	112